161 related articles for article (PubMed ID: 36720505)
21. HPV-negative tumors of the uterine cervix.
Nicolás I; Marimon L; Barnadas E; Saco A; Rodríguez-Carunchio L; Fusté P; Martí C; Rodriguez-Trujillo A; Torne A; Del Pino M; Ordi J
Mod Pathol; 2019 Jul; 32(8):1189-1196. PubMed ID: 30911077
[TBL] [Abstract][Full Text] [Related]
22. Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy.
Nagai Y; Toma T; Moromizato H; Maehama T; Asato T; Kariya K; Kanazawa K
Am J Obstet Gynecol; 2004 Dec; 191(6):1907-13. PubMed ID: 15592271
[TBL] [Abstract][Full Text] [Related]
23. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
24. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
Kagabu M; Nagasawa T; Tatsuki S; Fukagawa Y; Tomabechi H; Takatori E; Kaido Y; Shoji T; Baba T
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34072478
[No Abstract] [Full Text] [Related]
26. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
27. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer.
Song YJ; Kim JY; Lee SK; Lim HS; Lim MC; Seo SS; Kang S; Lee DO; Park SY
Int J Cancer; 2011 Aug; 129(4):896-902. PubMed ID: 21064095
[TBL] [Abstract][Full Text] [Related]
28. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy.
Wang CC; Lai CH; Huang HJ; Chao A; Chang CJ; Chang TC; Chou HH; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1111-20. PubMed ID: 20231068
[TBL] [Abstract][Full Text] [Related]
29. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas.
Graflund M; Sorbe B; Sigurdardóttir S; Karlsson M
Int J Gynecol Cancer; 2004; 14(5):896-902. PubMed ID: 15361201
[TBL] [Abstract][Full Text] [Related]
30. Molecular Diagnosis for Nodal Metastasis in Endoscopically Managed Cervical Cancer: The Accuracy of the APTIMA Test to Detect High-risk Human Papillomavirus Messenger RNA in Sentinel Lymph Nodes.
Köhler C; Le X; Dogan NU; Pfiffer T; Schneider A; Marnitz S; Bertolini J; Favero G
J Minim Invasive Gynecol; 2016; 23(5):748-52. PubMed ID: 26976197
[TBL] [Abstract][Full Text] [Related]
31. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment.
Lindel K; Burri P; Studer HU; Altermatt HJ; Greiner RH; Gruber G
Int J Gynecol Cancer; 2005; 15(2):278-84. PubMed ID: 15823112
[TBL] [Abstract][Full Text] [Related]
33. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract][Full Text] [Related]
34. Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
Mahantshetty U; Teni T; Naga P; Hotwani C; Umesh S; Kannan S; Hande V; Pawar S; Engineer R; Chopra S; Deodhar K; Maheshwari A; Gurram L; Gupta S; Shrivastava SK
Gynecol Oncol; 2018 Feb; 148(2):299-304. PubMed ID: 29203175
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients--a prospective study.
Lukaszuk K; Liss J; Gulczynski J; Nowaczyk M; Nakonieczny M; Piatkowski M; Sliwinski W; Baay M; Wozniak I; Maj B; Lukaszuk M
Gynecol Oncol; 2007 Mar; 104(3):721-6. PubMed ID: 17156830
[TBL] [Abstract][Full Text] [Related]
37. [Follow-up of high risk, human papillomavirus (HPV)-positive patients with cancer of the uterine cervix].
Hernádi Z; Sápy T; Kónya J; Veress G; Czeglédy J
Orv Hetil; 1997 May; 138(20):1249-53. PubMed ID: 9244858
[TBL] [Abstract][Full Text] [Related]
38. Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases.
Chen P; Zhang W; Yang D; Zhang W; Gao S
Med Sci Monit; 2019 Mar; 25():1894-1902. PubMed ID: 30864560
[TBL] [Abstract][Full Text] [Related]
39. The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Menso S; De Nictolis M; Romanini C; Biagini G
Cancer; 1998 Mar; 82(5):886-92. PubMed ID: 9486578
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the efficacy of prophylactic extended field irradiation in the concomitant chemoradiotherapy treatment of locally advanced cervical cancer, stage IIIB in the 2018 FIGO classification.
Meng Q; Liu X; Wang W; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2019 Dec; 14(1):228. PubMed ID: 31842919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
